Wyniki wyszukiwania

1

Milk as a new diagnostic tool for rapid detection of fascioliasis in dairy goats using excretory/secretory antigen

100%

Saad M. F., Attia M. M.

Acta Parasitologica

|

2021

|

tom 66

|

nr 2

2

Use of the PCR in a combined methodological approach for the study of human fascioliasis in an endemic area

100%

Carnevale S., Malandrini J. B., Pantano M. L., Sawicki M., Kamenetzky L., Soria C. C., Velasquez J. N.

Acta Parasitologica

|

2021

|

tom 66

|

nr 2

3

Artykuł dostępny w postaci pełnego tekstu - kliknij by otworzyć plik

Electrophoretic separation of Fasciola hepatica antigen

100%

Ziomko I., Cencek T.

Wiadomości Parazytologiczne

|

1998

|

tom 44

|

nr 3

4

Works on the nowadays treat of liver fluke [Fasciola hepatica] in dairy cattle

100%

Michalski M. M.

Wiadomości Parazytologiczne

|

1998

|

tom 44

|

nr 3

5

Evidence of Fasciola spp. resistance to albendazole, triclabendazole and bromofenofos in water buffaloes (Bubalus bubalis)

84%

Venturina V. M., Alejandro A. F., Baltazar C. P., Abes N. S., Mingala C. N.

Annals of Parasitology

|

2015

|

tom 61

|

nr 4

Fasciolosis caused by Fasciola spp. is considered the most important helminth infection of ruminants in tropical countries. Anthelmintic resistance has become a global concern. This study compared the efficacy of the commonly used anthelmintics, determined the toxicity level and any indication of resistance. Thirty two water buffaloes naturally-infected with Fasciola spp. were used to determine the efficacy of triclabendazole (TBZ), albendazole (ABZ), and bromofenofos (BRO) using Fecal Egg Count Reduction Test (FECRT). To test the toxicity of the drugs given, serum glutamic-pyruvic transaminase (SGPT) was evaluated before and within one week after treatment. One dose administration of ABZ registered an efficacy of 79.17%, 73.33% for TBZ and 70.83% for BRO. Efficacy in two dosetreatment group was 83.33% for both BRO and ABZ, and 90.00% for TBZ. Two dose-treatment was effective for TBZ (90%), ineffective for BRO and ABZ. SGPT levels were not significantly different between pre-treatment and posttreatment across all treatments. Giving one or two doses of anthelmintics, at one month interval, does not increase the efficacy of the three drugs tested. The study also implies that anthelmintic resistance may have developed in the animals.

6

Molecular diagnosis of natural fasciolosis by DNA detection in sheep faeces

84%

Carnevale S., Pantano M. L., Kamenetzky L., Malandrini J. B., Soria C. C., Velasquez J. N.

Acta Parasitologica

|

2015

|

tom 60

|

nr 2

7

Effect of papain and piperonyl butoxide/MGK-264 on the reproduction/development of Lymnaea acuminata

84%

Hanif F., Singh D. K.

Journal of Biology and Earth Sciences

|

2013

|

tom 03

|

nr 1

8

A survey on the adjuvant role of naloxone alone or combined with alum in vaccination against fasciolosis in BALB/c mice

84%

Azizi H., Mirzaeei H., Bagheri A., Bazi A., Khamesipour A., Yaghoobi H., Mirzapour A., Khatami M., Elikaee S.

Acta Parasitologica

|

2019

|

tom 64

|

nr 2

9

Lymnaeid snail vectors of fascioliasis, including the first finding of Lymnaea neotropica in Ecuador, assessed by ribosomal DNA sequencing in the Southern zone close to the Peru border

84%

Villavicencio A. F., Bargues M. D., Artigas P., Guaman R., Ulloa S. M., Romero J., Osca D., Mas-Coma S.

Acta Parasitologica

|

2019

|

tom 64

|

nr 4

10

Recent developments in recombinant proteins for diagnosis of human fascioliasis

84%

Mirzadeh A., Jafarihaghighi F., Kazemirad E., Sabzevar S. S., Tanipour M. H., Ardjmand M.

Acta Parasitologica

|

2021

|

tom 66

|

nr 1

11

Molluscicidal activity of Morus nigra against the freshwater snail Lymnaea acuminata

84%

Hanif F., Singh D. K.

Journal of Biology and Earth Sciences

|

2012

|

tom 02

|

nr 2

12

Variant abiotic factors and the infection of Fasciola gigantica larval stages in vector snail Indoplanorbis exustus

84%

Singh N., Kumar P., Singh D. K.

Journal of Biology and Earth Sciences

|

2012

|

tom 02

|

nr 2

13

CIAS detection of Fasciola hepatica/F. gigantica intermediate forms in bovines from Bangladesh

84%

Ahasan S. A., Valero M. A., Chowdhury E. H., Islam M. T., Islam M. R., Mondal M. M. H., Peixoto R. V., Berinde L., Panova M., Mas-Coma S.

Acta Parasitologica

|

2016

|

tom 61

|

nr 2

14

The effect of saprotrophic fungi on the development and hatching of Fasciola hepatica eggs

84%

Kolodziejczyk L., Mazurkiewicz-Zapalowicz K., Janda K., Dzika E.

Folia Biologica

|

2014

|

tom 62

|

nr 2

15

Molecular cloning and bioinformatic characterisation of FhPcW1, a new isoform of cathepsin L from adult Fasciola hepatica

84%

Jaros S., Zygner W., Januszkiewicz K., Jaros D., Wedrychowicz H.

Bulletin of the Veterinary Institute in Puławy

|

2010

|

tom 54

|

nr 4

The aim of this study was to clone new secretory antigen of Fasciola hepatica and to predict its availability for immune system. The new cathepsin L - FhPcW1 (F. hepatico cysteine proteinase Warsaw 1), GenBank accession: EF407948, cDNA was cloned from adult F. hepatica flukes using RACE-PCR method. FhPcW1 is encoded by a 1,066 bp mRNA with a predicted open reading frame (ORF) of 326 amino acids (predicted pl = 5.41, m.w. = 37.137 kDa). Performed bioinformatic analysis included alignments of the nucleotide and amino acid sequences, the ExPASy (Expert Protein Analysis System) proteomics server of the Swiss Institute of Bioinformatics and National Center for Biotechnology Information. Performed analyses allowed to suppose that FhPcW1 is a secreted protein, which contains signal peptide, serine, threonine, tyrosine phosphorylation sites and four tyrosine sulfation sites, and does not contain glycosylation sites. The ORF corresponding to FhPcW1 exhibited strong similarity to previously cloned cathepsins L from the F. hepatico as well as F. gigantica. Predicted biochemical characteristics fits to the described before F. hepatica cathepsin Ls. Moreover, three dimensional model and MHC types ligation strength prediction were performed. Analysis of MHC type I and II peptide binding suggests that FhPcW1 may have significant immunogenic potential. The potential HLA II epitopes are situated at the outer surface of this protein. Thus, these epitopes seems to be available for immune response, especially for antibodies. This result may show that FhPcW1 seems to be a promising antigen for vaccination against F. hepatica.

16

Cloning and heterologous expression of a novel cysteine protease from Fasciola hepatica newly excysted juveniles

84%

Ljunggren E. L., Jedlina-Panasiuk L., Kozak M.

Wiadomości Parazytologiczne. Suplement

|

2008

|

tom 54

17

Evaluation of Fasciola hepatica infections in cattle in Northeastern Algeria and the effects on both enzyme and hepatic damage, confirmed by scanning electron microscopy

84%

Taibi A., Aissi M., Harhoura K., Zenia S., Zait H., Hamrioui B.

Acta Parasitologica

|

2019

|

tom 64

|

nr 1

18

Response of Fasciola gigantica cercaria exposed to different photo and chemo stimulants

84%

Tripathi A. P., Singh V. K., Singh D. K.

Journal of Biology and Earth Sciences

|

2014

|

tom 04

|

nr 1

19

Human case of Fasciola gigantica-like infection, review of human fascioliasis reports in Nepal, and epidemiological analysis within the South Central Asia

84%

Sah R., Khadka S., Lakhey P. J., Pradhan S., Shah N. P., Singh Y. P., Mas-Coma S.

Acta Parasitologica

|

2018

|

tom 63

|

nr 3

20

Eco-friendly management of harmful snail population using Alstonia scholaris

84%

Chauhan S., Singh A.

Journal of Biology and Earth Sciences

|

2014

|

tom 04

|

nr 1

Ograniczanie wyników

Milk as a new diagnostic tool for rapid detection of fascioliasis in dairy goats using excretory/secretory antigen

Use of the PCR in a combined methodological approach for the study of human fascioliasis in an endemic area

Electrophoretic separation of Fasciola hepatica antigen

Works on the nowadays treat of liver fluke [Fasciola hepatica] in dairy cattle

Evidence of Fasciola spp. resistance to albendazole, triclabendazole and bromofenofos in water buffaloes (Bubalus bubalis)

Molecular diagnosis of natural fasciolosis by DNA detection in sheep faeces

Effect of papain and piperonyl butoxide/MGK-264 on the reproduction/development of Lymnaea acuminata

A survey on the adjuvant role of naloxone alone or combined with alum in vaccination against fasciolosis in BALB/c mice

Lymnaeid snail vectors of fascioliasis, including the first finding of Lymnaea neotropica in Ecuador, assessed by ribosomal DNA sequencing in the Southern zone close to the Peru border

Recent developments in recombinant proteins for diagnosis of human fascioliasis

Molluscicidal activity of Morus nigra against the freshwater snail Lymnaea acuminata

Variant abiotic factors and the infection of Fasciola gigantica larval stages in vector snail Indoplanorbis exustus

CIAS detection of Fasciola hepatica/F. gigantica intermediate forms in bovines from Bangladesh

The effect of saprotrophic fungi on the development and hatching of Fasciola hepatica eggs

Molecular cloning and bioinformatic characterisation of FhPcW1, a new isoform of cathepsin L from adult Fasciola hepatica

Cloning and heterologous expression of a novel cysteine protease from Fasciola hepatica newly excysted juveniles

Evaluation of Fasciola hepatica infections in cattle in Northeastern Algeria and the effects on both enzyme and hepatic damage, confirmed by scanning electron microscopy

Response of Fasciola gigantica cercaria exposed to different photo and chemo stimulants

Human case of Fasciola gigantica-like infection, review of human fascioliasis reports in Nepal, and epidemiological analysis within the South Central Asia

Eco-friendly management of harmful snail population using Alstonia scholaris